158 related articles for article (PubMed ID: 32520156)
1. Cardiac amyloidosis: non-invasive diagnosis.
Hotta VT; Giorgi MCP; Fernandes F; Abduch MCD; Falcão AMGM; Mady C
Rev Assoc Med Bras (1992); 2020 Mar; 66(3):345-352. PubMed ID: 32520156
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.
White JA; Fine NM
Curr Cardiol Rep; 2016 Aug; 18(8):77. PubMed ID: 27319007
[TBL] [Abstract][Full Text] [Related]
3. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease.
Di Bella G; Pizzino F; Minutoli F; Zito C; Donato R; Dattilo G; Oreto G; Baldari S; Vita G; Khandheria BK; Carerj S
Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1307-15. PubMed ID: 25190073
[TBL] [Abstract][Full Text] [Related]
4. Nuclear imaging for cardiac amyloidosis.
Noordzij W; Glaudemans AW; Longhi S; Slart RH; Lorenzini M; Hazenberg BP; Rapezzi C
Heart Fail Rev; 2015 Mar; 20(2):145-54. PubMed ID: 25424887
[TBL] [Abstract][Full Text] [Related]
5. Imaging in systemic amyloidosis.
Sachchithanantham S; Wechalekar AD
Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
[TBL] [Abstract][Full Text] [Related]
6. Multimodality imaging in cardiac amyloidosis: a primer for cardiologists.
Jurcuţ R; Onciul S; Adam R; Stan C; Coriu D; Rapezzi C; Popescu BA
Eur Heart J Cardiovasc Imaging; 2020 Aug; 21(8):833-844. PubMed ID: 32393965
[TBL] [Abstract][Full Text] [Related]
7. [The Changing Appearance of Cardiac Amyloidosis].
Mahrholdt H; Klingel K; Sechtem U
Dtsch Med Wochenschr; 2018 Sep; 143(18):1335-1343. PubMed ID: 30199915
[TBL] [Abstract][Full Text] [Related]
8. Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.
Simons M; Isner JM
Am J Cardiol; 1992 Feb; 69(4):425-7. PubMed ID: 1734663
[No Abstract] [Full Text] [Related]
9. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of cardiac imaging in amyloidosis.
Vidal-Perez R; Vázquez-García R; Barge-Caballero G; Bouzas-Mosquera A; Soler-Fernandez R; Larrañaga-Moreira JM; Crespo-Leiro MG; Vazquez-Rodriguez JM
World J Cardiol; 2020 Dec; 12(12):599-614. PubMed ID: 33391613
[TBL] [Abstract][Full Text] [Related]
11. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
12. [The importance of cardiac bio-marker assay for the stratification and monitoring of AL amyloidosis patients - single center experience].
Pika T; Lochman P; Vymětal J; Metelka R; Flodr P; Minařík J; Látalová P; Zapletalová J; Bačovský J; Sčudla V
Vnitr Lek; 2013 Sep; 59(9):776-81. PubMed ID: 24073949
[TBL] [Abstract][Full Text] [Related]
13. Multimodality imaging in cardiac amyloidosis: State-of-the-art review.
Timóteo AT; Rosa SA; Brás PG; Ferreira MJV; Bettencourt N
J Clin Ultrasound; 2022 Oct; 50(8):1084-1096. PubMed ID: 36218201
[TBL] [Abstract][Full Text] [Related]
14. Value of classical criteria for diagnosis of cardiac amyloidosis re-evaluated with magnetic resonance.
Pozo E; Sanz J
Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1133-6. PubMed ID: 25205232
[TBL] [Abstract][Full Text] [Related]
15. 11C-Pittsburgh B PET imaging in cardiac amyloidosis.
Lee SP; Lee ES; Choi H; Im HJ; Koh Y; Lee MH; Kwon JH; Paeng JC; Kim HK; Cheon GJ; Kim YJ; Kim I; Yoon SS; Seo JW; Sohn DW
JACC Cardiovasc Imaging; 2015 Jan; 8(1):50-59. PubMed ID: 25499132
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of echocardiography, cardiac magnetic resonance imaging and
Massalha S; Ruddy TD
J Nucl Cardiol; 2018 Dec; 25(6):2080-2083. PubMed ID: 28585032
[No Abstract] [Full Text] [Related]
17. Multi-modality imaging of cardiac amyloidosis: Contemporary update.
Wang TKM; Abou Hassan OK; Jaber W; Xu B
World J Radiol; 2020 Jun; 12(6):87-100. PubMed ID: 32742575
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic Peptides and Cardiac Troponins: Markers of Disease Progression and Risk in Light Chain Cardiac Amyloidosis.
Wees I; Hendren NS; Kaur G; Roth LR; Grodin JL
Curr Heart Fail Rep; 2023 Oct; 20(5):350-357. PubMed ID: 37428428
[TBL] [Abstract][Full Text] [Related]
19. Echocardiography and magnetic resonance imaging in cardiac amyloidosis.
von Kemp K; Beckers R; Vandenweghe J; Taeymans Y; Osteaux M; Block P
Acta Cardiol; 1989; 44(1):29-36. PubMed ID: 2711796
[TBL] [Abstract][Full Text] [Related]
20. Amyloid transthyretin cardiac amyloidosis: diagnosis and management.
Di Giovanni B; Gustafson D; Delgado DH
Expert Rev Cardiovasc Ther; 2019 Sep; 17(9):673-681. PubMed ID: 31478389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
